Markets
United Health Care Corporate Headquarters Campus
Getty Images

Move over Tesla, UnitedHealth is the battleground stock for retail traders this week as options trading explodes

UNH was the most-discussed ticker on r/wallstreetbets in the last week — and data from Robinhood suggests traders are mostly buyers.

Retail darlings like Palantir Technologies, Nvidia, and Tesla have had to make way for a new battleground stock on popular investing forums in the last week: embattled stock UnitedHealth.

After the shooting of its CEO last year, America’s largest healthcare insurance provider, UnitedHealth, has been under increased scrutiny — becoming a lightning rod for anger and debate over America’s healthcare system.

Now, the company’s sickly stock itself has become a flashpoint.

After plummeting by 50% between April 16 and May 16, UNH has attracted a legion of traders looking to profit from the wild swings in what used to be one of America’s most boring, stable companies, with data from SwaggyStocks — which tracks sentiment on sites like Reddit’s r/wallstreetbets — revealing that its the most-discussed ticker on the forum over the last seven days.

UNH Mentions
Sherwood News

Risk factors

Since reporting weak earnings in mid-April, UNH’s stock has been under pressure. On May 13, the company suspended its guidance, the same day CEO Andrew Witty abruptly stepped down for personal reasons, contributing to shares dropping another 18% in one day.

Some retail traders have taken swings at catching the falling knife by “buying the dip.” Those that did so post-Witty exit were burned just days later on May 15, when The Wall Street Journal reported that UnitedHealth was under investigation for possible Medicare fraud, triggering another 11% fall in the company’s equity. On that day there were more than 3,700 mentions of UNH on Reddit’s infamous investing forum, per data tracked by SwaggyStocks.

UNH stock
Sherwood News

So, why has UNH grabbed retail traders’ attention?

The simplest answer is that it’s been super volatile, and traders with short-term investing horizons like the opportunity that volatility brings, even if it also means a lot of risk. Data from Bloomberg confirms that a lot of action has spilled over into the options markets, with put and call volumes spiking 820% in the five days leading up to May 19, relative to the previous week of trading.

But, of course, plenty of stocks are volatile, so why has UNH captured the retail zeitgeist so strongly?

One explanation might be that UnitedHealth’s business — or perhaps more accurately, criticisms thereof — is increasingly prominent in internet culture, and therefore the minds of retail traders. Luigi Mangione, the prime suspect in the killing of UnitedHealth’s CEO Brian Thompson, has become something of a folk hero for people railing against corporate greed and America’s health system.

Could it be that Main Street investors have decided to put their money where their mouth is, betting against the American healthcare machine?

It’s a nice theory, but it doesn’t seem to quite add up. Options volumes jumped modestly around the time of Brian Thompson’s murder, and on Luigi Mangione’s subsequent arrest five days later in December of last year, but they didn’t do anything like what we’ve seen in the last week when the UNH price action was much more extreme. If this were a counterculture “Main Street vs. Wall Street” moment, it feels like the most plausible time for it to have happened would have been four to five months ago.

Furthermore, while it’s true that bets against the company have risen, so have bullish trades. Indeed, the put/call volume ratio for the last five days of trading is just 0.68 — a fairly unremarkable figure that means traders are still buying more calls than puts.

Data from Robinhood all but kills the idea that the spike in trading is politically motivated, with Robinhood’s tracking of retail traders revealing that they have mostly been bullish on UNH stock. Customers have been net buyers in each of the last 10 trading sessions.

(Sherwood Media is an editorially independent subsidiary of Robinhood Markets Inc.)

Robinhood Trading Trends
Sherwood News

A spate of large insider buys — most notably by the company’s new CEO, Stephen Hemsley, who reportedly spent $25 million acquiring UNH shares — helped to turn the stock around on Monday.

More likely, then, it seems that UNH was simply a candidate for old-fashioned dip-buying: an historically stable, (now) well-known company that’s hit a rough patch. Of course, the dip can always resume dipping.

More Markets

See all Markets
Tiny Scientists in Lab

String of acquisitions fuel biotech optimism

In the past month, the S&P Biotech ETF surpassed March 2020 levels.

markets

Micron jumps after rare double upgrade by BNP Paribas Exane, which lifts price target to Street high of $270

Micron, the best-performing member of the VanEck Semiconductor ETF this year, is jumping on Monday thanks to converting its biggest doubter on Wall Street into its biggest fan.

BNP Paribas Exane analyst Karl Ackerman went through with a rare double upgrade of the memory chip specialist to “outperform” from “underperform.” In the process, he more than doubled his price target on the stock to $270 — the highest among analysts surveyed by Bloomberg — from $100, which had previously been the lowest price target on the Street.

“We now fully embrace high-bandwidth memory (HBM) as a sustainable, separate growth vector, and we beleive we are in the early innings of a memory supercycle,” he wrote.

Separately, analysts at Evercore ISI also boosted their price target on Micron to $137 from $100.

markets

IonQ soars after announcing “significant advancement in quantum chemistry simulations”

IonQ is ripping higher in early trading after the quantum computing company announced “a significant advancement in quantum chemistry simulations.”

In particular, this demonstration, performed in collaboration with a major automotive manufacturer, was more accurate than classical computing in calculating “nuclear forces at critical points where big changes occur.”

Knowing how different compounds behave and respond to force has potentially very useful commercial applications because it helps us discern how those materials can best be designed and utilized for different purposes.

“This research demonstrates a clear path for quantum computing to enhance chemical simulations that are foundational to decarbonization technologies,” said Niccolo de Masi, chairman and CEO. “Our work goes beyond academic benchmarks. It demonstrates a practical capability that can be integrated into molecular dynamics workflows used across pharmaceuticals, battery, and chemical industries.”

IonQ is the most commercially advanced pure-play quantum computing company, generating over $52 million in revenues over the past 12 months, well more than D-Wave Quantum, Rigetti Computing, and Quantum Computing combined.

Now, is this the reason why IonQ (and its peers) are on a tear today? Maybe. There’s a big rebound in most speculative pockets of the market after Friday’s tariff threat induced a tumble.

At the very least, this is a useful excuse. Traders have been exceedingly happy to bid up shares of quantum computing companies on their long-term potential, often (ironically) through short-term call options.

markets

Rocket Lab may be “alternative to SpaceX in the making,” says Morgan Stanley

Rocket Lab surged early Monday after Morgan Stanley analysts lifted their price target on the stock to $68 from $20, making them the high bidder among analysts covering the popular, but still money-losing, commercial space launch company.

The $68 target — right around where the shares are currently trading — is the highest among the 17 analysts tracked by FactSet.

And while Morgan Stanley analysts couldn’t bring themselves to upgrade the stock to a “buy,” leaving their rating at “equal weight,” they gave the stock a pretty bullish review, writing:

“We see a potential alternative to SpaceX in the making. The company is mirroring SpaceX’s footsteps in a number of respects, including scaling up rocket lift capacity, embracing booster reusability, and ultimately moving out on a constellation of its own (ala Starlink). Meanwhile, successive Electron launches and a growing manifest reinforce the company’s already-impressive track record. The market, in our view, is now taking valuation cues for RKLB from SpaceX’s implied valuation, which has grown from a reported ~$100bn at the end of 2021 to ~$400bn today.”

Rocket Lab shares have emerged as a favorite of retail traders this year, thanks to their gain of more than 150%. The stock is up roughly 600% over the last 12 months.

markets

Broadcom soars after announcing deal with OpenAI to deploy 10 gigawatts of AI accelerators starting next year

Broadcom is spiking in early trading after the chip designer announced that it’s collaborating with OpenAI to develop and deploy 10 gigawatts of custom AI accelerators for use across data centers.

The companies said these racks and systems will start to be in service in the second half of 2026 and fully completed by the end of 2029.

Broadcom soared during its Q3 earnings call when CEO Hock Tan said the chip designer booked a major new customer that the Financial Times later reported was OpenAI. However, CNBC is reporting that Charlie Kawwas, Ph.D. and president of the semiconductor solutions group for Broadcom, indicated that OpenAI is not that mystery $10 billion buyer.

There were no details on financial terms in today’s press release, though The Wall Street Journal says the new agreement is worth “multiple billions of dollars,” citing people familiar with the matter.

“The racks include Broadcom’s end-to-end portfolio of Ethernet, PCIe and optical connectivity solutions, reaffirming our AI infrastructure portfolio leadership,” said Kawwas in the press release.

“By building our own chip, we can embed what we’ve learned from creating frontier models and products directly into the hardware, unlocking new levels of capability and intelligence,” said Greg Brockman, OpenAI cofounder and president.

The calendar is telling me it’s fall, but it really feels like OpenAI announcement season. Just last week, the ChatGPT developer struck a megadeal that sees it get an up to 10% stake in Advanced Micro Devices, rounding out a series of massive commitments that will require the venture to find (and burn) much more cash.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.